HS-20197 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,355 results for “HS-20197”

Trials

View all 896 →

Not yet recruiting

A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis

720 participants · First posted Feb 25, 2025

Not yet recruiting

A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors

322 participants · First posted Jul 11, 2023

A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer

1,080 participants · First posted May 16, 2024

Drugs

View all 261 →

HS-20117

HS-301

HS-10241

Organizations

KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES

Saudi Arabia

News

View all 197 →

Hansoh Pharma's HS-20197 Cleared for Clinical Trials in Advanced Solid Tumors

FDA Approves Bimzelx (bimekizumab-bkzx) for Moderate-to-Severe Hidradenitis Suppurativa

Secukinumab Demonstrates Improvement in Hidradenitis Suppurativa Symptoms and Psychiatric Comorbidities

Page 1 of 136